Jayne, D., & Schaier, M. (2017). Randomized trial of C5a receptor inhibitor avacopan in ANCA-associated vasculitis. Journal of the American Society of Nephrology, 28(9), . https://doi.org/10.1681/ASN.2016111179
Chicago Style (17th ed.) CitationJayne, David, and Matthias Schaier. "Randomized Trial of C5a Receptor Inhibitor Avacopan in ANCA-associated Vasculitis." Journal of the American Society of Nephrology 28, no. 9 (2017). https://doi.org/10.1681/ASN.2016111179.
MLA (9th ed.) CitationJayne, David, and Matthias Schaier. "Randomized Trial of C5a Receptor Inhibitor Avacopan in ANCA-associated Vasculitis." Journal of the American Society of Nephrology, vol. 28, no. 9, 2017, https://doi.org/10.1681/ASN.2016111179.
Warning: These citations may not always be 100% accurate.